| pubmed-article:15677794 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15677794 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:15677794 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:15677794 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
| pubmed-article:15677794 | lifeskim:mentions | umls-concept:C0445456 | lld:lifeskim |
| pubmed-article:15677794 | lifeskim:mentions | umls-concept:C0332161 | lld:lifeskim |
| pubmed-article:15677794 | lifeskim:mentions | umls-concept:C0246689 | lld:lifeskim |
| pubmed-article:15677794 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:15677794 | pubmed:dateCreated | 2005-1-28 | lld:pubmed |
| pubmed-article:15677794 | pubmed:abstractText | Several studies have demonstrated that endothelial dysfunction plays a central role in diabetic mortality and that the prooxidative effect of postprandial hyperglycemia may actively contribute to atherogenesis. Thus, we investigated the possible effect of short-acting (repaglinide) and long-acting (glibenclamide) insulin secretagogues on endothelial function in type 2 diabetic patients. | lld:pubmed |
| pubmed-article:15677794 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15677794 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15677794 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15677794 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15677794 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15677794 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15677794 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15677794 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15677794 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15677794 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15677794 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:15677794 | pubmed:issn | 0149-5992 | lld:pubmed |
| pubmed-article:15677794 | pubmed:author | pubmed-author:PaolissoGiuse... | lld:pubmed |
| pubmed-article:15677794 | pubmed:author | pubmed-author:ManzellaDanie... | lld:pubmed |
| pubmed-article:15677794 | pubmed:author | pubmed-author:GrellaRodolfo... | lld:pubmed |
| pubmed-article:15677794 | pubmed:author | pubmed-author:AbbatecolaAng... | lld:pubmed |
| pubmed-article:15677794 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15677794 | pubmed:volume | 28 | lld:pubmed |
| pubmed-article:15677794 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15677794 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15677794 | pubmed:pagination | 366-71 | lld:pubmed |
| pubmed-article:15677794 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15677794 | pubmed:meshHeading | pubmed-meshheading:15677794... | lld:pubmed |
| pubmed-article:15677794 | pubmed:meshHeading | pubmed-meshheading:15677794... | lld:pubmed |
| pubmed-article:15677794 | pubmed:meshHeading | pubmed-meshheading:15677794... | lld:pubmed |
| pubmed-article:15677794 | pubmed:meshHeading | pubmed-meshheading:15677794... | lld:pubmed |
| pubmed-article:15677794 | pubmed:meshHeading | pubmed-meshheading:15677794... | lld:pubmed |
| pubmed-article:15677794 | pubmed:meshHeading | pubmed-meshheading:15677794... | lld:pubmed |
| pubmed-article:15677794 | pubmed:meshHeading | pubmed-meshheading:15677794... | lld:pubmed |
| pubmed-article:15677794 | pubmed:meshHeading | pubmed-meshheading:15677794... | lld:pubmed |
| pubmed-article:15677794 | pubmed:meshHeading | pubmed-meshheading:15677794... | lld:pubmed |
| pubmed-article:15677794 | pubmed:meshHeading | pubmed-meshheading:15677794... | lld:pubmed |
| pubmed-article:15677794 | pubmed:meshHeading | pubmed-meshheading:15677794... | lld:pubmed |
| pubmed-article:15677794 | pubmed:meshHeading | pubmed-meshheading:15677794... | lld:pubmed |
| pubmed-article:15677794 | pubmed:meshHeading | pubmed-meshheading:15677794... | lld:pubmed |
| pubmed-article:15677794 | pubmed:meshHeading | pubmed-meshheading:15677794... | lld:pubmed |
| pubmed-article:15677794 | pubmed:meshHeading | pubmed-meshheading:15677794... | lld:pubmed |
| pubmed-article:15677794 | pubmed:meshHeading | pubmed-meshheading:15677794... | lld:pubmed |
| pubmed-article:15677794 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15677794 | pubmed:articleTitle | Repaglinide administration improves brachial reactivity in type 2 diabetic patients. | lld:pubmed |
| pubmed-article:15677794 | pubmed:affiliation | Department of Geriatric Medicine and Metabolic Diseases VI, Internal Medicine, Piazza Miraglia 2 I-80138, Napoli, Italy. | lld:pubmed |
| pubmed-article:15677794 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15677794 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15677794 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:15677794 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15677794 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15677794 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15677794 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15677794 | lld:pubmed |
